Study on the problems in the adverse event report of clinical trials

Hiroyuki Furukawa, Masahiro Uchikata, Junko Ishizaki, Yukiko Matsushima, Sachie Osada, Shizue Matsuda, Eiko Yokoyama, Sakae Shimizu, Hisashi Bunko, Ken'ichi Miyamoto

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

The decision making process by patients of whether or not to participate in clinical trials occurs in relation to the balance of profits obtained from clinical trials and the disadvantage (especially, health damage) experienced in clinical trials, and the information about a critical adverse event is an important factor in the decision making process. Among all report cases (1,907 cases) provided to our hospital, 1,014 cases (53%) were known adverse reactions and 844 cases (44%) were newly detected, The invesigators (physicians) judged the causal relationship between the investigational drug and adverse events observed, as follows; "definite" 228 cases (12%), "probable" 555 cases (29%), "unlikely" 118 cases (6%), and "unknown" 907 cases (48%). Because about one half of all events make up "unknown" events, the burden and responsibility of the medical institutions which undertake clinical trials to evaluate the clinical importance of reported events are very large. Many of the events are observed in the drugs which are available commercially in foreign countries at present, and the burden of information management is great for the institutions. Another new problem is the difference in the interpretation of information given in English, such as CIOMS report style and MedWatch report style, which may cause some confusion. It is possible to enhance the accuracy of judging a causal relationship by standardization of the information item and establishing the collection system. The transmission of information using electronic media can increase the efficiency of data management in both the medical institutions and the clinical trials subjects.

Original languageEnglish
Pages (from-to)287-294
Number of pages8
JournalJapanese Journal of Clinical Pharmacology and Therapeutics
Volume32
Issue number6
Publication statusPublished - 2001
Externally publishedYes

Fingerprint

Clinical Trials
Decision Making
Investigational Drugs
Information Management
Physicians
Health
Pharmaceutical Preparations

Keywords

  • Adverse event
  • Causal relationship
  • Decision making
  • Good clinical practice

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

Furukawa, H., Uchikata, M., Ishizaki, J., Matsushima, Y., Osada, S., Matsuda, S., ... Miyamoto, K. (2001). Study on the problems in the adverse event report of clinical trials. Japanese Journal of Clinical Pharmacology and Therapeutics, 32(6), 287-294.

Study on the problems in the adverse event report of clinical trials. / Furukawa, Hiroyuki; Uchikata, Masahiro; Ishizaki, Junko; Matsushima, Yukiko; Osada, Sachie; Matsuda, Shizue; Yokoyama, Eiko; Shimizu, Sakae; Bunko, Hisashi; Miyamoto, Ken'ichi.

In: Japanese Journal of Clinical Pharmacology and Therapeutics, Vol. 32, No. 6, 2001, p. 287-294.

Research output: Contribution to journalArticle

Furukawa, H, Uchikata, M, Ishizaki, J, Matsushima, Y, Osada, S, Matsuda, S, Yokoyama, E, Shimizu, S, Bunko, H & Miyamoto, K 2001, 'Study on the problems in the adverse event report of clinical trials', Japanese Journal of Clinical Pharmacology and Therapeutics, vol. 32, no. 6, pp. 287-294.
Furukawa H, Uchikata M, Ishizaki J, Matsushima Y, Osada S, Matsuda S et al. Study on the problems in the adverse event report of clinical trials. Japanese Journal of Clinical Pharmacology and Therapeutics. 2001;32(6):287-294.
Furukawa, Hiroyuki ; Uchikata, Masahiro ; Ishizaki, Junko ; Matsushima, Yukiko ; Osada, Sachie ; Matsuda, Shizue ; Yokoyama, Eiko ; Shimizu, Sakae ; Bunko, Hisashi ; Miyamoto, Ken'ichi. / Study on the problems in the adverse event report of clinical trials. In: Japanese Journal of Clinical Pharmacology and Therapeutics. 2001 ; Vol. 32, No. 6. pp. 287-294.
@article{1840aa6307dc4a4e86ca55c16a003285,
title = "Study on the problems in the adverse event report of clinical trials",
abstract = "The decision making process by patients of whether or not to participate in clinical trials occurs in relation to the balance of profits obtained from clinical trials and the disadvantage (especially, health damage) experienced in clinical trials, and the information about a critical adverse event is an important factor in the decision making process. Among all report cases (1,907 cases) provided to our hospital, 1,014 cases (53{\%}) were known adverse reactions and 844 cases (44{\%}) were newly detected, The invesigators (physicians) judged the causal relationship between the investigational drug and adverse events observed, as follows; {"}definite{"} 228 cases (12{\%}), {"}probable{"} 555 cases (29{\%}), {"}unlikely{"} 118 cases (6{\%}), and {"}unknown{"} 907 cases (48{\%}). Because about one half of all events make up {"}unknown{"} events, the burden and responsibility of the medical institutions which undertake clinical trials to evaluate the clinical importance of reported events are very large. Many of the events are observed in the drugs which are available commercially in foreign countries at present, and the burden of information management is great for the institutions. Another new problem is the difference in the interpretation of information given in English, such as CIOMS report style and MedWatch report style, which may cause some confusion. It is possible to enhance the accuracy of judging a causal relationship by standardization of the information item and establishing the collection system. The transmission of information using electronic media can increase the efficiency of data management in both the medical institutions and the clinical trials subjects.",
keywords = "Adverse event, Causal relationship, Decision making, Good clinical practice",
author = "Hiroyuki Furukawa and Masahiro Uchikata and Junko Ishizaki and Yukiko Matsushima and Sachie Osada and Shizue Matsuda and Eiko Yokoyama and Sakae Shimizu and Hisashi Bunko and Ken'ichi Miyamoto",
year = "2001",
language = "English",
volume = "32",
pages = "287--294",
journal = "Japanese Journal of Clinical Pharmacology and Therapeutics",
issn = "0388-1601",
publisher = "Japanese Society of Clinical Pharmacology and Therapeutics",
number = "6",

}

TY - JOUR

T1 - Study on the problems in the adverse event report of clinical trials

AU - Furukawa, Hiroyuki

AU - Uchikata, Masahiro

AU - Ishizaki, Junko

AU - Matsushima, Yukiko

AU - Osada, Sachie

AU - Matsuda, Shizue

AU - Yokoyama, Eiko

AU - Shimizu, Sakae

AU - Bunko, Hisashi

AU - Miyamoto, Ken'ichi

PY - 2001

Y1 - 2001

N2 - The decision making process by patients of whether or not to participate in clinical trials occurs in relation to the balance of profits obtained from clinical trials and the disadvantage (especially, health damage) experienced in clinical trials, and the information about a critical adverse event is an important factor in the decision making process. Among all report cases (1,907 cases) provided to our hospital, 1,014 cases (53%) were known adverse reactions and 844 cases (44%) were newly detected, The invesigators (physicians) judged the causal relationship between the investigational drug and adverse events observed, as follows; "definite" 228 cases (12%), "probable" 555 cases (29%), "unlikely" 118 cases (6%), and "unknown" 907 cases (48%). Because about one half of all events make up "unknown" events, the burden and responsibility of the medical institutions which undertake clinical trials to evaluate the clinical importance of reported events are very large. Many of the events are observed in the drugs which are available commercially in foreign countries at present, and the burden of information management is great for the institutions. Another new problem is the difference in the interpretation of information given in English, such as CIOMS report style and MedWatch report style, which may cause some confusion. It is possible to enhance the accuracy of judging a causal relationship by standardization of the information item and establishing the collection system. The transmission of information using electronic media can increase the efficiency of data management in both the medical institutions and the clinical trials subjects.

AB - The decision making process by patients of whether or not to participate in clinical trials occurs in relation to the balance of profits obtained from clinical trials and the disadvantage (especially, health damage) experienced in clinical trials, and the information about a critical adverse event is an important factor in the decision making process. Among all report cases (1,907 cases) provided to our hospital, 1,014 cases (53%) were known adverse reactions and 844 cases (44%) were newly detected, The invesigators (physicians) judged the causal relationship between the investigational drug and adverse events observed, as follows; "definite" 228 cases (12%), "probable" 555 cases (29%), "unlikely" 118 cases (6%), and "unknown" 907 cases (48%). Because about one half of all events make up "unknown" events, the burden and responsibility of the medical institutions which undertake clinical trials to evaluate the clinical importance of reported events are very large. Many of the events are observed in the drugs which are available commercially in foreign countries at present, and the burden of information management is great for the institutions. Another new problem is the difference in the interpretation of information given in English, such as CIOMS report style and MedWatch report style, which may cause some confusion. It is possible to enhance the accuracy of judging a causal relationship by standardization of the information item and establishing the collection system. The transmission of information using electronic media can increase the efficiency of data management in both the medical institutions and the clinical trials subjects.

KW - Adverse event

KW - Causal relationship

KW - Decision making

KW - Good clinical practice

UR - http://www.scopus.com/inward/record.url?scp=0041319172&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0041319172&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0041319172

VL - 32

SP - 287

EP - 294

JO - Japanese Journal of Clinical Pharmacology and Therapeutics

JF - Japanese Journal of Clinical Pharmacology and Therapeutics

SN - 0388-1601

IS - 6

ER -